Search research articles
Contact Us
Filters
Showing results (501-510 of 519) with videos related to
Page
of 52
Sort By:
Human Molecular Genetics
|
January 13, 2006
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells
Thomas H Gillingwater, Thomas M Wishart, Philip E Chen, et al.
Journal of the American Society of Nephrology : JASN
|
June 28, 2020
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial
Manjula Kurella Tamura, Sarah A Gaussoin, Nicholas M Pajewski, et al.
American Journal of Nephrology
|
September 9, 2020
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants
Vasantha Jotwani, Pranav S Garimella, Ronit Katz, et al.
JAMA Neurology
|
October 11, 2016
Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage
Gregoire Boulouis, Ellis S van Etten, Andreas Charidimou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 14, 2017
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
Daniel E Weiner, Sarah A Gaussoin, John Nord, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 20, 2021
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure
Manjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 17, 2016
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study
Paul E Drawz, Nicholas M Pajewski, Jeffrey T Bates, et al.
Journal of the American Heart Association
|
July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT
Lama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 28, 2020
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT
Stephen P Juraschek, Addison A Taylor, Jackson T Wright, et al.
AJNR. American Journal of Neuroradiology
|
April 27, 2023
Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial
C Shah, D Srinivasan, G Erus, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 519) with videos related to
Sort By:
Page
of 52
Human Molecular Genetics
|
January 13, 2006
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells
Thomas H Gillingwater, Thomas M Wishart, Philip E Chen, et al.
Journal of the American Society of Nephrology : JASN
|
June 28, 2020
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial
Manjula Kurella Tamura, Sarah A Gaussoin, Nicholas M Pajewski, et al.
American Journal of Nephrology
|
September 9, 2020
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants
Vasantha Jotwani, Pranav S Garimella, Ronit Katz, et al.
JAMA Neurology
|
October 11, 2016
Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage
Gregoire Boulouis, Ellis S van Etten, Andreas Charidimou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 14, 2017
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
Daniel E Weiner, Sarah A Gaussoin, John Nord, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 20, 2021
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure
Manjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 17, 2016
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study
Paul E Drawz, Nicholas M Pajewski, Jeffrey T Bates, et al.
Journal of the American Heart Association
|
July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT
Lama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 28, 2020
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT
Stephen P Juraschek, Addison A Taylor, Jackson T Wright, et al.
AJNR. American Journal of Neuroradiology
|
April 27, 2023
Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial
C Shah, D Srinivasan, G Erus, et al.
Page
of 52